-
-
-
-
-
-
-
Servier to acquire Day One Biopharmaceuticals for $2.5 billion
-
-
-
-
-
-
-
Increasing unusual option volume: GTM CRVS IBRX DAWN PRGO RVMD EWG
-
-
-
-
-
-
-
Day One Biopharmaceuticals (DAWN) December 10 and 11 calls active
-
-
-
-
-
-
-
Day One Biopharmaceuticals, Inc. (DAWN) Tops Q1 EPS by 7c
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Day One Biopharmaceuticals (DAWN)
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

